ImmuSmol's News

ImmuSmol raises 500 000 € to advance cancer immunotherapy programme


ImmuSmol is pleased to announce it has raised 500 000 € to progress its monoclonal antibodies for cancer immunotherapy to in vivo proof-of-concept (POC).

More ...

Polyclonal antibodies to Tryptophan / Kynurenine metabolites now available

06/13/2014 Polyclonal antibodies to Kynurenine metabolites

NEW! ImmuSmol releases rabbit polyclonal antibodies against Tryptophan / Kynurenine metabolites, all validated for IHC in human samples.
Picture: L-Kynurenine detection by IHC in human colorectal cancer tissue using anti-L-Kynurenine rabbit pAb.

More ...

ImmuSmol at BioEurope Spring 2014

03/10/2014 ImmuSmol at BioEurope Spring 2014

ImmuSmol will be in Turin for Bioeurope Spring 2014, on March 10-12. Contact us to arrange a meeting!

More ...

Antibodies against small molecules - IHC & ELISA applications

03/03/2014 Antibodies against small molecules - ImmuSmol services

A short overview of ImmuSmol's services for the development of antibodies against small molecules, and their subsequent validation for small molecule detection by ELISA or IHC.

More ...